Showing 1 - 10 of 38,089
Im Zuge des GKV-Modernisierungsgesetzes wird seit dem 1. 1. 2004 eine sog. Praxisgebühr von 10 Euro pro Quartal für ambulante Arzt- und Zahnarztbesuche erhoben. Neben einem Beitrag zur Konsolidierung der Finanzlage der GKV sollte die Praxisgebühr auch eine Verhaltensänderung der Versicherten...
Persistent link: https://www.econbiz.de/10010310707
Im Zuge des GKV-Modernisierungsgesetzes wird seit dem 1. 1. 2004 eine sog. Praxisgebühr von 10 Euro pro Quartal für ambulante Arzt- und Zahnarztbesuche erhoben. Neben einem Beitrag zur Konsolidierung der Finanzlage der GKV sollte die Praxisgebühr auch eine Verhaltensänderung der Versicherten...
Persistent link: https://www.econbiz.de/10010981099
As part of the Statutory Health Insurance Modernization Act a co-payment of €10 per quarter for the first contact at a physician's or a dentist's office has been introduced with effect of 1stJanuary 2004. Apart from contributing to the financial consolidation of the Statutory Health Insurance...
Persistent link: https://www.econbiz.de/10005068642
, die Zahl nicht notwendiger Arztbesuche oder Mehrfachuntersuchungen zu verringern. -- Praxisgebühr ; Selbstbeteiligung … ; Verhaltensänderung ; Arztkontakt ; sozioökonomische Variablen …
Persistent link: https://www.econbiz.de/10009661731
The German health care reform of 2004 imposes a charge of 10 Euro for the first visit to a doctor in each quarter of the year. At first glance, there is no inhibiting effect of this fee on utilization in the German Socio-Economic Panel. However, this study reveals that the true effect is diluted...
Persistent link: https://www.econbiz.de/10003951754
Using SOEP panel data and difference-in-differences methods, this study is the first to empirically evaluate the effectiveness of four different health care cost containment measures within an integrated framework. The four measures investigated were introduced in Germany in 1997 to reduce moral...
Persistent link: https://www.econbiz.de/10008826715
Many countries with national health care providers and health insurances regulate the market for pharmaceuticals to steer drug demand and to control expenses. For example, they introduce reference pricing or tiered co-payments to enhance drug substitution and competition. Since 2006, Germany...
Persistent link: https://www.econbiz.de/10009522774
This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems - coinsurance and indemnity insurance - are compared with respect to changes in copayments and public health...
Persistent link: https://www.econbiz.de/10010223102
We use a Regression Discontinuity Design (RDD) to evaluate the impact of cost-sharing on the use of health services. In the Italian health system, individuals reaching age 65 and earning low incomes are given total exemption from cost-sharing for health services consumption. Since the...
Persistent link: https://www.econbiz.de/10011453425
This paper evaluates the impact of reference pricing on prices and co-payments in the (German) market for off-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference price affects the consumers' co-payments in a...
Persistent link: https://www.econbiz.de/10010489291